Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Matsuda

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Psychiatry and Clinical Neurosciences|May 29, 2026
Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesiaYuki Matsuda, Yuta Suzuki
Proceedings. Biological Sciences|August 27, 2024
Comparative genomics reveals convergent signals associated with the high metabolism and longevity in birds and batsYuki Matsuda, Takashi Makino
Experimental Brain Research|November 17, 2025
Associations between susceptibility to the rubber hand illusion and action reproduction accuracyMasanori Sakamoto, Yuki Matsuda
Chemical Communications (Cambridge, England)|April 10, 2020
Cu-Catalyzed three-component coupling reactions using nitriles, 1,3-dienes and silylboranesYuki Matsuda, Yasushi Tsuji, Tetsuaki Fujihara
Journal of Psychiatric Research|October 2, 2013
Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: an updated meta-analysis of randomized placebo-controlled trialsYuki Matsuda, Taro Kishi, Nakao Iwata
Plos One|February 8, 2014
Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trialsTaro Kishi, Yuki Matsuda, Nakao Iwata
Psychopharmacology|May 17, 2017
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysisTaro Kishi, Yuki Matsuda, Nakao Iwata
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled TrialsTaro Kishi, Yuki Matsuda, Nakao Iwata
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 7, 2007
Successive splitting of autowaves in a nonlinear chemical reaction mediumTaiji Okano, Yuki Matsuda, Kenji Miyakawa
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|November 27, 2014
The position of blonanserin as a treatment for schizophreniaTaro Kishi, Yuki Matsuda, Nakao Iwata
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Psychiatry and Clinical Neurosciences|May 29, 2026
Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesiaYuki Matsuda, Yuta Suzuki
Proceedings. Biological Sciences|August 27, 2024
Comparative genomics reveals convergent signals associated with the high metabolism and longevity in birds and batsYuki Matsuda, Takashi Makino
Experimental Brain Research|November 17, 2025
Associations between susceptibility to the rubber hand illusion and action reproduction accuracyMasanori Sakamoto, Yuki Matsuda
Chemical Communications (Cambridge, England)|April 10, 2020
Cu-Catalyzed three-component coupling reactions using nitriles, 1,3-dienes and silylboranesYuki Matsuda, Yasushi Tsuji, Tetsuaki Fujihara
Journal of Psychiatric Research|October 2, 2013
Efficacy and safety of NMDA receptor antagonists augmentation therapy for schizophrenia: an updated meta-analysis of randomized placebo-controlled trialsYuki Matsuda, Taro Kishi, Nakao Iwata
Plos One|February 8, 2014
Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trialsTaro Kishi, Yuki Matsuda, Nakao Iwata
Psychopharmacology|May 17, 2017
Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: a meta-analysisTaro Kishi, Yuki Matsuda, Nakao Iwata
Journal of Alzheimer'S Disease : JAD|June 6, 2018
Combination Therapy of Serotonin Reuptake Inhibitors and Memantine for Obsessive- Compulsive Disorder: A Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled TrialsTaro Kishi, Yuki Matsuda, Nakao Iwata
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|February 7, 2007
Successive splitting of autowaves in a nonlinear chemical reaction mediumTaiji Okano, Yuki Matsuda, Kenji Miyakawa
Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists|November 27, 2014
The position of blonanserin as a treatment for schizophreniaTaro Kishi, Yuki Matsuda, Nakao Iwata
Pageof 13